Literature DB >> 26909500

Creeping posterior synechiae following hyperopic iris-fixated phakic implants.

Marco Messina1, Mohamed Elalfy1, Usama Fares1, Noha Ghoz1, Balraj Mavi1, Harminder Dua2,3.   

Abstract

The purpose of this study was to report on the occurrence and management of posterior synechiae (PS) in three hyperopic eyes after iris-fixated anterior chamber phakic IOL implantation. This is a case report of a 55-year-old man and a 55-year-old lady who had undergone iris-fixated anterior chamber phakic IOL implantation to correct hyperopic astigmatism (one eye) and hyperopia (both eyes), respectively. The three eyes developed creeping PS and pigment dispersion within 4-6 weeks of surgery. Synechiolysis and pupil stretching in one eye did not work as the synechiae promptly recurred. Definitive management in the form of removal of the phakic implant and phacoemulsification with lens implant was successful in restoring normal vision in all three eyes. Although implantation of phakic intraocular lenses has been reported to be very effective for the correction of moderate to high degrees of ametropia, this complication can occur in hyperopic eyes. Pigment dispersion has been reported in myopic eyes also, but PS seem to be more an issue with hyperopic eyes. Age of the patient may also be a factor. This information is important in the selection and counselling of patients.

Entities:  

Keywords:  Iris-fixated lenses; Phakic IOL; Posterior synechia

Mesh:

Year:  2016        PMID: 26909500     DOI: 10.1007/s10792-016-0202-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Pigment dispersion and Artisan phakic intraocular lenses: crystalline lens rise as a safety criterion.

Authors:  Georges Baïkoff; Grégoire Bourgeon; Horacio Jitsuo Jodai; Aline Fontaine; Fernando Viera Lellis; Laure Trinquet
Journal:  J Cataract Refract Surg       Date:  2005-04       Impact factor: 3.351

2.  Five-year follow-up of 399 phakic Artisan-Verisyse implantation for myopia, hyperopia, and/or astigmatism.

Authors:  Jose Luis Güell; Merce Morral; Oscar Gris; Javier Gaytan; Maite Sisquella; Felicidad Manero
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079

Review 3.  Phakic intraocular lenses part 1: historical overview, current models, selection criteria, and surgical techniques.

Authors:  Jose Luis Güell; Merce Morral; Daniel Kook; Thomas Kohnen
Journal:  J Cataract Refract Surg       Date:  2010-11       Impact factor: 3.351

Review 4.  Phakic intraocular lenses: part 2: results and complications.

Authors:  Thomas Kohnen; Daniel Kook; Merce Morral; Jose Luis Güell
Journal:  J Cataract Refract Surg       Date:  2010-12       Impact factor: 3.351

5.  Recurrent intraocular inflammation after implantation of the Artiflex phakic intraocular lens for the correction of high myopia.

Authors:  Nayyirih G Tahzib; Fred A G J Eggink; Peter M Frederik; Rudy M M A Nuijts
Journal:  J Cataract Refract Surg       Date:  2006-08       Impact factor: 3.351

6.  Three-year follow-up of the Artisan phakic intraocular lens for hypermetropia.

Authors:  Ruchi Saxena; Monika Landesz; Bastiaantje Noordzij; Gregorius P M Luyten
Journal:  Ophthalmology       Date:  2003-07       Impact factor: 12.079

7.  Initial results of endothelial cell counts after Artisan lens for phakic eyes: an evaluation of the United States Food and Drug Administration Ophtec Study.

Authors:  Mihai Pop; Yves Payette
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

  7 in total
  2 in total

1.  Severe pigment dispersion after iris-claw phakic intraocular lens implantation.

Authors:  Virgilio Galvis; Néstor I Carreño; Alejandro Tello; Andrea N Laiton
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

2.  Anterior Uveitis with Posterior Synechia and Iris Atrophy Following Implantation of a Phakic Intraocular Lens.

Authors:  Mehrdad Mohammadpour; Mehdi Mazloumi; Masoud Khorrami-Nejad
Journal:  Int Med Case Rep J       Date:  2020-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.